Toledo-Stuardo, K. et al. Therapeutic antibodies in oncology: an immunopharmacological overview. Cancer Immunol. Immunother. 73, 242 (2024).
Mirjalili, S. Z., Sabourian, R., Sadeghalvad, M. & Rezaei, N. Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders. Int. Immunopharmacol. 101, 108305 (2021).
Casadevall, A. & Paneth, N. in Current Topics in Microbiology and Immunology (eds Ahmed, R. et al.) (Springer, 2024).
WHO. WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance (2024).
Klemm, E. J., Wong, V. K. & Dougan, G. Emergence of dominant multidrug-resistant bacterial clades: Lessons from history and whole-genome sequencing. Proc. Natl Acad. Sci. USA 115, 12872–12877 (2018).
Gonzalez-Ferrer, S. et al. Finding order in the chaos: outstanding questions in Klebsiella pneumoniae pathogenesis. Infect. Immun. 89, e00693-20 (2021).
Falcone, M. et al. Efficacy of ceftazidime–avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing Enterobacterales. Clin. Infect. Dis. 72, 1871–1878 (2021).
Pilato, V. D. et al. Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation. Lancet Microbe 3, e224–e234 (2022).
Martin, M. J. et al. Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy. Proc. Natl. Acad. Sci. USA 118, e2110227118 (2021).
Tascini, C. et al. In vivo evolution to high-level cefiderocol resistance of NDM-1–producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission. Clin. Microbiol. Infect. 30, 398–400 (2024).
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D. & Coulthard, K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 25, 11–25 (2005).
Martin, M. J. et al. A panel of diverse Klebsiella pneumoniae clinical isolates for research and development. Microb. Genomics 9, mgen000967 (2023).
Turton, J. F., Perry, C., McGowan, K., Turton, J. A. & Hope, R. Klebsiella pneumoniae sequence type 147: a high-risk clone increasingly associated with plasmids carrying both resistance and virulence elements. J. Med. Microbiol. 73, 001823 (2024).
Troisi, M. et al. A new dawn for monoclonal antibodies against antimicrobial resistant bacteria. Front. Microbiol. 13, 1080059 (2022).
Banerjee, K. et al. Patient-derived antibody data yields development of broadly cross-protective monoclonal antibody against ST258 carbapenem-resistant Klebsiella pneumoniae. Microbiol. Spectr. 10, e01760-22 (2022).
Pennini, M. E. et al. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. Nat. Commun. 8, 1991 (2017).
Cohen, T. S. et al. Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4. JCI Insight 2, e92774 (2017).
Rollenske, T. et al. Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen. Nat. Immunol. 19, 617–624 (2018).
Diago-Navarro, E. et al. Novel, broadly reactive anticapsular antibodies against carbapenem-resistant Klebsiella pneumoniae protect from infection. mBio 9, e00091-18 (2018).
Diago-Navarro, E. et al. Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clin. Vaccine Immunol. 24, e00456-16 (2017).
Wantuch, P. L. et al. Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS Pathog. 19, e1011367 (2023).
Wang, Q. et al. Target-agnostic identification of functional monoclonal antibodies against Klebsiella Pneumoniae multimeric MrkA fimbrial subunit. J. Infect. Dis. 213, 1800–1808 (2016).
Aruta, M. G., Carducci, M., Micoli, F., Necchi, F. & Rossi, O. Increasing the high throughput of a luminescence-based serum bactericidal assay (L-SBA). BioTech 10, 19 (2021).
Falcone, M. et al. Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020. Eurosurveillance 25, 2001779 (2020).
Wang, W. et al. Different regulatory mechanisms of the capsule in hypervirulent Klebsiella pneumonia: “direct” wcaJ variation vs. “indirect” rmpA regulation. Front. Cell. Infect. Microbiol. 13, 1108818 (2023).
Kos, V. & Whitfield, C. A membrane-located glycosyltransferase complex required for biosynthesis of the d-galactan I lipopolysaccharide O antigen in Klebsiella pneumoniae. J. Biol. Chem. 285, 19668–19678 (2010).
Merrifield, E. H. & Stephen, A. M. Structural studies on the capsular polysaccharide from Klebsiella serotype k64. Carbohydr. Res. 74, 241–257 (1979).
Clarke, B. R. et al. Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae. J. Biol. Chem. 293, 4666–4679 (2018).
De Jong, R. N. et al. A novel platform for the potentiation of therapeutic antibodies based on antigen-dependent formation of IgG hexamers at the cell surface. PLoS Biol. 14, e1002344 (2016).
Abdelraouf, K., Kim, A., Krause, K. M. & Nicolau, D. P. In vivo efficacy of plazomicin alone or in combination with meropenem or tigecycline against Enterobacteriaceae isolates exhibiting various resistance mechanisms in an immunocompetent murine septicemia model. Antimicrob. Agents Chemother. 62, e01074-18 (2018).
Park, J. Y. et al. Establishment of experimental murine peritonitis model with hog gastric mucin for carbapenem-resistant Gram-negative bacteria. Infect. Chemother. 49, 57 (2017).
Lapp, Z. et al. Regional spread of bla NDM-1-containing Klebsiella pneumoniae ST147 in post-acute care facilities. Clin. Infect. Dis. 73, 1431–1439 (2021).
Starkova, P. et al. Emergence of hybrid resistance and virulence plasmids harboring New Delhi metallo-β-lactamase in Klebsiella pneumoniae in Russia. Antibiotics 10, 691 (2021).
Wyres, K. L. et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 12, 11 (2020).
Zhou, K. et al. Novel subclone of carbapenem-resistant Klebsiella pneumoniae sequence type 11 with enhanced virulence and transmissibility, China. Emerg. Infect. Dis. 26, 289–297 (2020).
Zhao, D. et al. The emergence of novel sequence type strains reveals an evolutionary process of intraspecies clone shifting in ICU-spreading carbapenem-resistant Klebsiella pneumoniae. Front. Microbiol. 12, 691406 (2021).
Wang, J., Feng, Y. & Zong, Z. Worldwide transmission of ST11-KL64 carbapenem-resistant Klebsiella pneumoniae: an analysis of publicly available genomes. mSphere 8, e00173-23 (2023).
Kumar, A. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34, 1589–1596 (2006).
Cortés, G. et al. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 70, 2583–2590 (2002).
Regueiro, V., Campos, M. A., Pons, J., Albertí, S. & Bengoechea, J. A. The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells. Microbiology 152, 555–566 (2006).
March, C. et al. Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PLoS ONE 8, e56847 (2013).
Held, T. K., Jendrike, N. R. M., Rukavina, T., Podschun, R. & Trautmann, M. Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains. Infect. Immun. 68, 2402–2409 (2000).
Berry, S. K. et al. Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae. mAbs 14, 2006123 (2022).
Wassil, J. et al. Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial. Lancet Infect. Dis. 24, 308–318 (2024).
Xiong, H. et al. Innate lymphocyte/Ly6Chi monocyte crosstalk promotes Klebsiella pneumoniae clearance. Cell 165, 679–689 (2016).
Wang, J. et al. Caspase-11 deficiency impairs neutrophil recruitment and bacterial clearance in the early stage of pulmonary Klebsiella pneumoniae infection. Int. J. Med. Microbiol. 307, 490–496 (2017).
Xiong, H. et al. Distinct contributions of neutrophils and CCR2+ monocytes to pulmonary clearance of different Klebsiella pneumoniae strains. Infect. Immun. 83, 3418–3427 (2015).
Bansept, F. et al. Enchained growth and cluster dislocation: A possible mechanism for microbiota homeostasis. PLoS Comput. Biol. 15, e1006986 (2019).
Wyres, K. L. et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb. Genom. 2, e000102 (2016).
Andreano, E. et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell 184, 1821–1835 e1816 (2021).
Gormus, B. J. & Wheat, R. W. Polysaccharides of type 6 Klebsiella. J. Bacteriol. 108, 1304–1309 (1971).
Micoli, F., Bagnoli, F., Rappuoli, R. & Serruto, D. The role of vaccines in combatting antimicrobial resistance. Nat. Rev. Microbiol. 19, 287–302 (2021).
Vinogradov, E. et al. Structures of lipopolysaccharides from Klebsiella pneumoniae. Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. J. Biol. Chem. 277, 25070–25081 (2002).
Ravenscroft, N., Stephen, A. M. & Merrifield, E. H. Bacteriophage-associated lyase activity against Klebsiella serotype K64 capsular polysaccharide. Carbohydr. Res. 167, 257–267 (1987).
Nonne, F. et al. Development and application of a high-throughput method for the purification and analysis of surface carbohydrates from Klebsiella pneumoniae. Biology 13, 256 (2024).
